These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20005539)

  • 1. Clinical observation paper: fatty liver and metabolic syndrome: is it a burden for the future generations?
    Nobili V; Agostoni C
    Metabolism; 2010 Jun; 59(6):831-3. PubMed ID: 20005539
    [No Abstract]   [Full Text] [Related]  

  • 2. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
    Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic fat deposition and the metabolic syndrome in obese children and adolescents.
    Cali AM; Caprio S
    Horm Res; 2009 Jan; 71 Suppl 1():2-7. PubMed ID: 19153496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and respiratory comorbidities of childhood obesity.
    Fennoy I
    Pediatr Ann; 2010 Mar; 39(3):140-6. PubMed ID: 20302245
    [No Abstract]   [Full Text] [Related]  

  • 7. The natural history of nonalcoholic fatty liver disease: insights from children and mice.
    Ahima RS
    Gastroenterology; 2008 Dec; 135(6):1860-2. PubMed ID: 19000676
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.
    den Boer M; Voshol PJ; Kuipers F; Havekes LM; Romijn JA
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):644-9. PubMed ID: 14715643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease and metabolic syndrome: a concise review.
    Streba LA; Cârstea D; Mitruţ P; Vere CC; Dragomir N; Streba CT
    Rom J Morphol Embryol; 2008; 49(1):13-20. PubMed ID: 18273497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, hepatic metabolism and disease.
    Edmison JM; Kalhan SC; McCullough AJ
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 63():163-72; discussion 172-6, 259-68. PubMed ID: 19346775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is low birth weight responsible for metabolic syndrome in India?
    Gupta S
    Med Hypotheses; 2007; 69(4):962-3. PubMed ID: 17368746
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonalcoholic fatty liver and insulin resistance among petrochemical workers.
    Cotrim HP; Carvalho F; Siqueira AC; Lordelo M; Rocha R; De Freitas LA
    JAMA; 2005 Oct; 294(13):1618-20. PubMed ID: 16204660
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From a glucocentric to a lipocentric approach towards metabolic syndrome.
    Mittra S; Bansal VS; Bhatnagar PK
    Drug Discov Today; 2008 Mar; 13(5-6):211-8. PubMed ID: 18342796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin resistance in non-alcoholic fatty liver disease].
    Park JH
    Korean J Hepatol; 2006 Mar; 12(1):16-30. PubMed ID: 16565603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome and nonalcoholic fatty liver disease.
    Collantes RS; Ong JP; Younossi ZM
    Panminerva Med; 2006 Mar; 48(1):41-8. PubMed ID: 16633331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children.
    Nobili V; Marcellini M; Marchesini G; Vanni E; Manco M; Villani A; Bugianesi E
    Diabetes Care; 2007 Oct; 30(10):2638-40. PubMed ID: 17536073
    [No Abstract]   [Full Text] [Related]  

  • 18. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: hepatic steatosis and insulin resistance.
    Lonardo A; Lombardini S; Ricchi M; Scaglioni F; Loria P
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():64-70. PubMed ID: 16225477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of abnormal liver enzymes and metabolic syndrome in obese adolescent females with polycystic ovary syndrome.
    Barfield E; Liu YH; Kessler M; Pawelczak M; David R; Shah B
    J Pediatr Adolesc Gynecol; 2009 Oct; 22(5):318-22. PubMed ID: 19576817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.